Understanding Certificates of Analysis (COAs)

What Is a Certificate of Analysis?

A Certificate of Analysis (COA) is a document issued by either the manufacturer or an independent third-party laboratory that details the results of quality testing performed on a specific batch of product. For research peptides, a COA typically reports on purity, identity, sterility, and contamination levels. It is the most important quality indicator available to researchers purchasing unregulated research compounds.

In Canada's unregulated research peptide market, where products are not subject to Health Canada oversight, a COA serves as a researcher's primary tool for verifying that what's on the label is actually in the vial. A reputable supplier will provide a COA for every batch sold. If a supplier cannot or will not provide a COA, that is a significant red flag.

Key Components of a Peptide COA

1. HPLC Purity Analysis

High-Performance Liquid Chromatography (HPLC) is the gold standard for peptide purity measurement. HPLC separates a sample into its individual components and measures what percentage of the total is the desired peptide versus impurities.

What to look for:

• ≥98% purity: Research grade. Suitable for most in vitro and in vivo research.
• ≥95% purity: Acceptable for many research applications but may contain more side products.
• <95% purity: Below standard for serious research. May contain significant impurities that confound results.
• ≥99% purity: Pharmaceutical grade. The highest standard, rarely necessary for basic research.

The HPLC chromatogram (the graph) should show one dominant peak with minimal smaller peaks. A “clean” chromatogram with a single sharp peak indicates good purity. Multiple secondary peaks suggest incomplete purification or degradation.

2. Mass Spectrometry (MS) — Identity Confirmation

Mass spectrometry measures the molecular weight of the peptide. This confirms that the product is actually the peptide claimed on the label — not a different peptide, a degradation product, or a different compound entirely.

What to look for:

• Observed molecular weight should match the theoretical molecular weight within a tolerance of ±0.1% or ±1 Da (Dalton).
• The spectrum should show a clear, dominant peak at the expected mass-to-charge ratio (m/z).
• Common MS techniques include ESI-MS (Electrospray Ionisation) and MALDI-TOF. Both are acceptable.

For example, BPC-157 has a theoretical molecular weight of approximately 1,419.5 Da. The observed mass on the COA should be very close to this value. If the observed mass is significantly different, the product may not be BPC-157.

3. Amino Acid Sequence Verification

Some advanced COAs include amino acid sequencing data, which confirms not just the molecular weight but the exact sequence of amino acids. This is the most definitive identity test but is not always provided by research chemical suppliers due to cost.

4. Endotoxin Testing (LAL Test)

Endotoxins are bacterial cell wall fragments (lipopolysaccharides) that can cause severe inflammatory reactions. The Limulus Amebocyte Lysate (LAL) test measures endotoxin levels in the product.

What to look for:

• <0.25 EU/mg: The typical acceptable limit for injectable research products
• <5 EU/kg: The FDA limit for human injectable pharmaceuticals (for reference)
• Not tested: Some research-grade suppliers skip endotoxin testing. This is acceptable for in vitro research but concerning for in vivo applications.

5. Sterility Testing

Sterility testing confirms the absence of viable microorganisms. This is particularly important for injectable peptides.

• Result should state “No growth detected” or “Sterile”
• Testing should follow USP <71> or equivalent methodology
• Like endotoxin testing, not all research-grade suppliers perform sterility testing

6. Residual Solvent Analysis

During peptide synthesis, various solvents are used (TFA, acetonitrile, DMF). Residual solvent analysis measures how much of these solvents remains in the final product.

• TFA (trifluoroacetic acid): Almost always present as a counterion. TFA content can affect peptide weight — some products specify “TFA salt” to account for this.
• Acetonitrile: Should be <410 ppm (ICH Q3C guideline)
• Other solvents: Should meet ICH Q3C Class 2 or Class 3 limits

7. Water Content (Karl Fischer)

Karl Fischer titration measures the water content of lyophilised peptides. Low water content is important for stability.

• Acceptable: <5–10% water content for most lyophilised peptides
• Higher water content suggests incomplete lyophilisation and may reduce shelf life

Red Flags: When a COA Might Be Unreliable

Third-Party vs In-House Testing

COAs can be issued by the manufacturer (in-house) or by an independent third-party laboratory. Understanding the difference is important:

In-house COAs are produced by the supplier's own quality control laboratory. They are a baseline expectation — every reputable supplier should provide these. However, they carry an inherent conflict of interest: the entity selling the product is also the one certifying its quality.

Third-party COAs are produced by independent analytical laboratories with no financial relationship to the supplier. These are the gold standard of quality verification. An independent lab has no incentive to inflate results. Look for labs with ISO 17025 accreditation or equivalent.

The best suppliers provide both: an in-house COA with every order and third-party verification available on request or published regularly for each batch.

COA Verification: Going Beyond Trust

If you want to independently verify a COA, several options exist:

• Send a sample to an independent lab: Canadian analytical laboratories like SGS Canada, Bureau Veritas, and Intertek offer peptide analysis services. Expect to pay $200–600 per analysis.
• Cross-reference the laboratory: If a third-party lab is named on the COA, contact them directly to verify the report number and results.
• Compare across suppliers: Purchase the same peptide from two different suppliers and compare COAs. Significant discrepancies warrant further investigation.
• Check community resources: Online peptide research communities sometimes share comparative testing data.

Canadian-Specific Considerations

Canada's research peptide market is unregulated by Health Canada, which means there is no government authority verifying the accuracy of COAs or the quality of products sold as “research chemicals.” This places the responsibility squarely on the researcher to perform due diligence.

• Canadian suppliers vs international: Canadian-based suppliers may offer faster shipping (important for peptide stability) but are not inherently more reliable than international suppliers. Quality depends on the manufacturer and the testing protocols, not the supplier's location.
• Customs and import: Peptides imported from outside Canada may be inspected by CBSA. Having a COA available can facilitate customs clearance for research chemicals.
• NPN numbers: Some suppliers sell peptide-containing products with Natural Product Numbers (NPNs). These products have been reviewed by Health Canada for safety, efficacy, and quality — but are limited to specific peptides and formulations (typically topical cosmetic products like GHK-Cu creams). Proper storage and handling is equally important for maintaining the purity verified by a COA.

Minimum COA Standards for Serious Research

At minimum, a COA for research-grade peptides should include:

• HPLC purity percentage with chromatogram image (≥98%)
• Mass spectrometry identity confirmation with spectrum
• Batch/lot number linking the COA to your specific product
• Date of analysis
• Laboratory identification (name and accreditation)

Additional tests (endotoxin, sterility, amino acid analysis, residual solvents) strengthen confidence and are expected from premium suppliers, particularly for in vivo research applications.